Long-chain omega-3 fatty acids could have neuroprotective properties against dementia, which is becoming a major global public health issue. We conducted a systematic review of the literature to ...
Background: Cognitive impairment is a significant complication in Parkinson’s disease (PD), impacting quality of life and increasing caregiver burden. This study investigates the association between ...
Introduction Accumulating evidence suggests that glucagon-like peptide-1 (GLP-1) receptor agonists may have therapeutic effects against Parkinson’s disease (PD); however, clinical evidence has not yet ...
Background: Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease that often causes cognitive impairment. This study aimed to investigate the association between MS and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback